Turbocharging Your Next Gen LNP End-To-End Development to Deliver Curative Promises to Patients

Following exciting industry updates from Verve Therapeutics’ GalNAc-LNP for PCSK9 for HFpEF treatment, to Recode’s 5th element, the 2nd LNP Formulation & Process Development Summit is your must-attend meeting as this nanoparticle continues to dominate the biopharmaceutical industry in 2023.

New for 2023, we have curated 3 streams of content for 2^nd iteration of the summit:

• In depth discussions divulging IP and regulatory compliance for LNP drug products
• Maximized LNP flexibility and versatility for payloads beyond mRNA vaccines with other RNA, DNA, gene therapy and gene editing possibilities
• Lipid Chemistry & Discovery Track: Novel lipid discovery and particle engineering to customize LNP composition for next generation delivery vehicle
• Formulation & Process Development Track: Optimize your LNP development techniques for enhanced manufacturability and product quality, and overcome stability issues of LNP-nucleic acid drug products
• LNP CMC & Manufacturing Track: Elevating your process control, CQAs framework for CMC, GMP compliance for seamless scale-up

This summit will offer the most comprehensive content and exclusive data, equipping you with end-to-end LNP development journey to exploit this lucrative non-viral delivery vehicle for various payloads to your destined cells and organs.

In collaboration with Intellia Therapeutics, Pfizer, Sanofi, ReCode Therapeutics, Akagera Medicines, the 2nd LNP Formulation & Process Development Summit is committed to serving you with their lessons learned to supercharge your pipeline and deliver curative promises to patients.

Join us to stay at the forefront of science, network with 350+ LNP Biology, Chemistry, Formulation & Process Development, Tech Ops & Manufacturing experts to gain competitive advantage to exploit LNP potentials!

To know more visit: https://ter.li/ol6e27